SCHEMBL1709289

SCHEMBL1709289

CCC(=O)[C@H](C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL268198 1.00
SCHEMBL1709336 1.00
Acetic Acid SCHEMBL28852386 0.92 TDP1 (0.38)
Ethyl Acetate SCHEMBL28852383 0.82 ALDH1A1 (0.58)
SCHEMBL15992208 0.81 MMP1 (0.41)
SCHEMBL11128512 0.81 TDP1 (0.37)
SCHEMBL2528138 0.79
SCHEMBL11466259 0.79
SCHEMBL637645 0.79
SCHEMBL2153461 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170098788-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-04-06 US disclosed
US-9487570-B2 Glucagon like peptide analogs, composition, and method of use BETTA PHARMACEUTICALS CO., LTD (CN) 2016-11-08 US disclosed
US-20120088770-A1 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO PRISM BIOLAB CORPORATION (JP) 2012-04-12 US disclosed
US-7199265-B2 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones KARO BIO AB (SE) 2007-04-03 US disclosed